Searched for
FDA PHASE
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...- In 1979, old salmon cans were stored in an Alaskan cannery, and decades later, when scientists cracked them open, a rising worm count revealed something unexpected about changing ocean food websOld canned salmon from Alaska reveals a significant increase in parasitic worms. Scientists studied cans dating back to 1979. This rise in ...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- Tata Elxsi unveils AnaTel, an AI-powered platform for healthcare software engineering and regulatory complianceTata Elxsi’s AnaTel reflects the growing shift toward AI-native healthcare software engineering, bringing AI-driven automation into regulat...
- Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- What is shelf-stable synthetic blood? The scientific advancement that could transform battlefield and emergency careA revolutionary synthetic blood is nearing human trials. This freeze-dried product can be stored for years at room temperature. It can be r...
- Gammon India spurts on Rs 1,700-crore order winWeak earnings have been weighing on the stock performance. The stock has lost more than half of its market value so far this year.
- Dr Reddy's signs commercialisation deal with HatchtechDr Reddy's said Hatchtech in September 2014 had announced positive results from its two pivotal phase three clinical studies.
- KEI Industries rallies as Q1 net more than triplesKEI Industries climbed over 6 per cent in intraday trades after the company said its net profit jumped more than three times.
- Lupin gets USFDA approval to market HIV drug; stock upLupin moved higher in trade as the Mumbai-based drug maker got a tentative approval from the USFDA to market Darunavir Ethanolate tablets.
- Hot stock: Goldman Sachs sees over 45% upside in Essar OilGoldman Sachs has maintained ‘buy’ rating on Essar Oil with a target price of Rs 110, an upside of over 45 per cent from the current market...
- Venus Remedies gets Australian patent approval for VancoplusDrug firm Venus Remedies today said it has received approval from the Australian Patent office (APO) for its product 'Vancoplus'.
- Lupin gets tentative USFDA approval for Pregabalin; stk upLupin’s subsidiary Lupin Pharmaceuticals Inc has received tentative ANDA approval for its Pregabalin capsules from the USFDA.
- Lupin, Natco tie up to market breast cancer tabletsDrug firms Lupin Ltd and Natco Pharma today said that they have entered into an alliance to jointly market generic Lapatinib Ditosylate tab...
- Bafna Pharma gets Ghana's approval for hypertension drugBafna Pharmaceuticals on Wednesday said it has received Ghana health regulator's approval to sell Atenolol tablets, used in the treatment o...
Load More
